封面
市場調查報告書
商品編碼
1386400

動物用藥品市場報告:2030 年趨勢、預測與競爭分析

Veterinary Medication Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

動物用藥品趨勢及預測

預計到 2030 年,全球動物用藥品市場將達到 622 億美元,2024 年至 2030 年複合年成長率為 7.1%。市場的主要驅動力是寵物主人數量的增加、全球畜牧業人口的增加以及動物慢性疾病風險的增加。全球動物用藥品市場前景廣闊,獸藥局和零售獸藥市場蘊藏商機。

動物用藥品市場洞察

Lucintel 預測,腸外藥物由於其易於獲得且起效快,將繼續成為最大的區隔市場。

在這個市場中,預計獸醫院藥局將在預測期內出現高速成長。

預計北美地區在預測期內將出現最高的成長。

本報告回答了 11 個關鍵問題:

  • Q.1. 區隔市場中最有前途和高成長的機會是什麼?
  • Q.2.哪個區隔市場將以更快的速度成長?為什麼?
  • Q.3.哪些地區未來會出現更快的成長?為什麼?
  • Q.4. 影響市場動態的主要因素有哪些?市場的主要課題和商業風險是什麼?
  • Q.5. 這個市場的商業風險和競爭威脅是什麼?
  • Q.6.這個市場有哪些新趨勢?為什麼?
  • Q.7.市場客戶需求有何改變?
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位?
  • Q.9.這個市場的主要企業有哪些?主要企業採取哪些策略配合措施來發展業務?
  • Q.10. 該市場上的競爭產品有哪些?由於材料或產品替代而導致市場佔有率下降的威脅有多大?
  • Q.11.過去五年發生了哪些併購事件,對產業產生了哪些影響?

目錄

第1章執行摘要

第2章全球動物用藥品市場:市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與課題

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢(2018-2023)與預測(2024-2030)
  • 全球動物用藥品市場趨勢(2018-2023)與預測(2024-2030)
  • 全球動物用藥品市場(依產品)
    • 藥物
    • 疫苗
    • 藥用飼料添加劑
  • 依給藥途徑分類的全球動物用藥品市場
    • 口服
    • 胃腸外的
    • 外用
  • 依配銷通路分類的全球動物用藥品市場
    • 動物醫院藥房
    • 零售獸藥局
  • 依動物類型分類的全球動物用藥品市場
    • 伴同性動物
    • 家畜

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球動物用藥品市場區域分佈
  • 北美動物用藥品市場
  • 歐洲動物用藥品市場
  • 亞太動物用藥品市場
  • 其他區域動物用藥品市場

第5章競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球動物用藥品市場成長機會(依產品)
    • 依給藥途徑給藥的全球動物用藥品市場成長機會
    • 依配銷通路的全球動物用藥品市場成長機會
    • 依動物類型分類的全球動物用藥品市場成長機會
    • 依地區分類的全球動物用藥品市場成長機會
  • 全球動物用藥品市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球動物用藥品市場的產能
    • 全球動物用藥品市場的合併、收購和合資企業
    • 認證和許可

第7章主要企業概況

  • Virbac
  • Merck
  • Archer Daniels Midland
  • Dechra Pharmaceuticals
  • Ceva Sante Animale
  • Boehringer Ingelheim
  • Soparfin
  • Elanco Animal Health
  • Evonik Industries AG
  • Zoetis
簡介目錄

Veterinary Medication Trends and Forecast

The future of the global veterinary medication market looks promising with opportunities in the veterinary hospital pharmacy and retail veterinary pharmacy markets. The global veterinary medication market is expected to reach an estimated $62.2 billion by 2030 with a CAGR of 7.1% from 2024 to 2030. The major drivers for this market are growing number of pet ownership, increasing global livestock population, and rising risk of chronic diseases among animals.

A more than 150-page report is developed to help in your business decisions.

Veterinary Medication by Segment

The study includes a forecast for the global veterinary medication by product, route of administration, distribution channel, animal type, and region.

Veterinary Medication Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Drugs
  • Vaccines
  • Medicated Feed Additives

Veterinary Medication Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:

  • Oral Route
  • Parenteral Route
  • Topical Route

Veterinary Medication Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Veterinary Hospitals Pharmacies
  • Retail Veterinary Pharmacies

Veterinary Medication Market by Animal Type [Shipment Analysis by Value from 2018 to 2030]:

  • Companion Animals
  • Livestock Animals

Veterinary Medication Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Veterinary Medication Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies veterinary medication companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the veterinary medication companies profiled in this report include-

  • Virbac
  • Merck
  • Archer Daniels Midland
  • Dechra Pharmaceuticals
  • Ceva Sante Animale
  • Boehringer Ingelheim
  • Soparfin
  • Elanco Animal Health
  • Evonik Industries AG
  • Zoetis

Veterinary Medication Market Insights

Lucintel forecasts that parenteral will remain the largest segment due to its easy availability and quick onset of action.

Within this market, veterinary hospital pharmacy is expected to witness higher growth over the forecast period.

North America is expected to witness highest growth over the forecast period.

Features of the Global Veterinary Medication Market

Market Size Estimates: Veterinary medication market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Veterinary medication market size by various segments, such as by product, route of administration, distribution channel, animal type, and region in terms of ($B).

Regional Analysis: Veterinary medication market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, route of administrations, distribution channels, animal types, and regions for the veterinary medication market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the veterinary medication market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the veterinary medication market size?

Answer: The global veterinary medication market is expected to reach an estimated $62.2 billion by 2030.

Q.2 What is the growth forecast for veterinary medication market?

Answer: The global veterinary medication market is expected to grow with a CAGR of 7.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the veterinary medication market?

Answer: The major drivers for this market are growing number of pet ownership, increasing global livestock population, and rising risk of chronic diseases among animals.

Q4. What are the major segments for veterinary medication market?

Answer: The future of the veterinary medication market looks promising with opportunities in the veterinary hospital pharmacy and retail veterinary pharmacy markets.

Q5. Who are the key veterinary medication market companies?

Answer: Some of the key veterinary medication companies are as follows:

  • Virbac
  • Merck
  • Archer Daniels Midland
  • Dechra Pharmaceuticals
  • Ceva Sante Animale
  • Boehringer Ingelheim
  • Soparfin
  • Elanco Animal Health
  • Evonik Industries AG
  • Zoetis

Q6. Which veterinary medication market segment will be the largest in future?

Answer: Lucintel forecasts that parenteral will remain the largest segment due to its easy availability and quick onset of action.

Q7. In veterinary medication market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the veterinary medication market by product (drugs, vaccines, and medicated feed additives), route of administration (oral route, parenteral route, and topical route), distribution channel (veterinary hospitals pharmacies and retail veterinary pharmacies), animal type (companion animals and livestock animals), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Veterinary Medication Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Veterinary Medication Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Veterinary Medication Market by Product
    • 3.3.1: Drugs
    • 3.3.2: Vaccines
    • 3.3.3: Medicated Feed Additives
  • 3.4: Global Veterinary Medication Market by Route of Administration
    • 3.4.1: Oral Route
    • 3.4.2: Parenteral Route
    • 3.4.3: Topical Route
  • 3.5: Global Veterinary Medication Market by Distribution Channel
    • 3.5.1: Veterinary Hospitals Pharmacies
    • 3.5.2: Retail Veterinary Pharmacies
  • 3.6: Global Veterinary Medication Market by Animal Type
    • 3.6.1: Companion Animals
    • 3.6.2: Livestock Animals

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Veterinary Medication Market by Region
  • 4.2: North American Veterinary Medication Market
    • 4.2.2: North American Veterinary Medication Market by Route of Administration: Oral Route, Parenteral Route, and Topical Route
  • 4.3: European Veterinary Medication Market
    • 4.3.1: European Veterinary Medication Market by Product: Drugs, Vaccines, and Medicated Feed Additives
    • 4.3.2: European Veterinary Medication Market by Route of Administration: Oral Route, Parenteral Route, and Topical Route
  • 4.4: APAC Veterinary Medication Market
    • 4.4.1: APAC Veterinary Medication Market by Product: Drugs, Vaccines, and Medicated Feed Additives
    • 4.4.2: APAC Veterinary Medication Market by Route of Administration: Oral Route, Parenteral Route, and Topical Route
  • 4.5: ROW Veterinary Medication Market
    • 4.5.1: ROW Veterinary Medication Market by Product: Drugs, Vaccines, and Medicated Feed Additives
    • 4.5.2: ROW Veterinary Medication Market by Route of Administration: Oral Route, Parenteral Route, and Topical Route

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Veterinary Medication Market by Product
    • 6.1.2: Growth Opportunities for the Global Veterinary Medication Market by Route of Administration
    • 6.1.3: Growth Opportunities for the Global Veterinary Medication Market by Distribution Channel
    • 6.1.4: Growth Opportunities for the Global Veterinary Medication Market by Animal Type
    • 6.1.5: Growth Opportunities for the Global Veterinary Medication Market by Region
  • 6.2: Emerging Trends in the Global Veterinary Medication Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Veterinary Medication Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Veterinary Medication Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Virbac
  • 7.2: Merck
  • 7.3: Archer Daniels Midland
  • 7.4: Dechra Pharmaceuticals
  • 7.5: Ceva Sante Animale
  • 7.6: Boehringer Ingelheim
  • 7.7: Soparfin
  • 7.8: Elanco Animal Health
  • 7.9: Evonik Industries AG
  • 7.10: Zoetis